Levy, J H <br/><br/>
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.  [electronic resource] 

 -  Circulation  Oct 1995 
 - 2236-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-7322 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.92.8.2236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aprotinin--administration & dosage<br/>Blood Loss, Surgical--prevention & control<br/>Blood Transfusion<br/>Blood Volume<br/>Coronary Artery Bypass<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Hemostatics--administration & dosage<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Postoperative Complications--epidemiology<br/>Prospective Studies<br/>Renal Insufficiency--epidemiology<br/>Reoperation<br/>Risk Factors<br/>Serine Proteinase Inhibitors--administration & dosage